Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sigesbeckia pubescens Makino extract is derived from the aerial parts of the annual plant Sigesbeckia pubescens, a member of the Asteraceae family native to East Asia. It has a long history in traditional Chinese and Korean medicine for treating inflammatory conditions such as arthritis, rheumatic pain, backache, sciatica, hypertension, malaria, and neurasthenia[1][3][4][5]. The primary bioactive constituents include diterpenoids (notably kirenol derivatives), flavonoids, sesquiterpenoids, and triterpenoids[3]. Modern research demonstrates anti-inflammatory and analgesic effects through modulation of immune responses (cellular/humoral/nonspecific immunity) and cytokine production[1][3]. Mechanistically, it inhibits proinflammatory chemokine production by modulating the Janus kinase 2/signal transducer and activator of transcription proteins 1/3 (JAK2/STAT1/STAT3) pathway in skin cells[4][6], supporting its use for musculoskeletal diseases as well as atopic dermatitis. In the UK it is licensed as an over-the-counter herbal medicine for joint/muscle pain; in the US it is available as a dietary supplement for joint health[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sigesbeckia pubescens Makino extract.